The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

INTRODUCTION: ALK gene rearrangement is observed in a small subset (3–7%) of non-small cell lung cancer (NSCLC) patients. The efficacy of crizotinib was shown in lung cancer patients harbouring ALK rearrangement. Nowadays, the analysis of ALK gene rearrangement is added to molecular examination of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojas-Krawczyk, Kamila, Krawczyk, Paweł Adam, Ramlau, Rodryg Adam, Szumiło, Justyna, Kozielski, Jerzy, Kalinka-Warzocha, Ewa, Bryl, Maciej, Knopik-Dąbrowicz, Alina, Spychalski, Łukasz, Szczęsna, Aleksandra, Rydzik, Ewelina, Milanowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934043/
https://www.ncbi.nlm.nih.gov/pubmed/24592134
http://dx.doi.org/10.5114/wo.2013.38758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934043/
https://www.ncbi.nlm.nih.gov/pubmed/24592134
http://dx.doi.org/10.5114/wo.2013.38758

Ejemplares similares